aluates Reports

$ 0.0

Automative

Global Drugs for Short Bowel Syndrome Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-19D6153

Global Drugs for Short Bowel Syndrome Market Insights and Forecast to 2028

BUY CHAPTERS

Global Drugs for Short Bowel Syndrome Market Research Report 2025

Code: QYRE-Auto-19D6153

Report

September 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ardelyx Inc

Emmaus Life Sciences

GLyPharma Therapeutic

Merck

Naia Pharmaceuticals

Nutrinia

OxThera

Sancilio & Company

Takeda

Zealand Pharma

Sancilio & Company

Drugs for Short Bowel Syndrome Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drugs for Short Bowel Syndrome Market

The global market for Drugs for Short Bowel Syndrome was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drugs for Short Bowel Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Short Bowel Syndrome.

The Drugs for Short Bowel Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Short Bowel Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Short Bowel Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs for Short Bowel Syndrome Market Report

Report Metric	Details
Report Name	Drugs for Short Bowel Syndrome Market
CAGR	5%
Segment by Type	GLP-2 Growth Hormone Glutamine Other
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company, Takeda, Zealand Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Short Bowel Syndrome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs for Short Bowel Syndrome Market report?

Ans: The main players in the Drugs for Short Bowel Syndrome Market are Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company, Takeda, Zealand Pharma

What are the Application segmentation covered in the Drugs for Short Bowel Syndrome Market report?

Ans: The Applications covered in the Drugs for Short Bowel Syndrome Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Drugs for Short Bowel Syndrome Market report?

Ans: The Types covered in the Drugs for Short Bowel Syndrome Market report are GLP-2, Growth Hormone, Glutamine, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 GLP-2

1.2.3 Growth Hormone

1.2.4 Glutamine

1.2.5 Other

1.3 Market by Application

1.3.1 Global Drugs for Short Bowel Syndrome Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2020-2031)

2.2 Global Drugs for Short Bowel Syndrome Growth Trends by Region

2.2.1 Global Drugs for Short Bowel Syndrome Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drugs for Short Bowel Syndrome Historic Market Size by Region (2020-2025)

2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2026-2031)

2.3 Drugs for Short Bowel Syndrome Market Dynamics

2.3.1 Drugs for Short Bowel Syndrome Industry Trends

2.3.2 Drugs for Short Bowel Syndrome Market Drivers

2.3.3 Drugs for Short Bowel Syndrome Market Challenges

2.3.4 Drugs for Short Bowel Syndrome Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue

3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2020-2025)

3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2020-2025)

3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drugs for Short Bowel Syndrome Revenue

3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio

3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2024

3.5 Global Key Players of Drugs for Short Bowel Syndrome Head office and Area Served

3.6 Global Key Players of Drugs for Short Bowel Syndrome, Product and Application

3.7 Global Key Players of Drugs for Short Bowel Syndrome, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Short Bowel Syndrome Breakdown Data by Type

4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2020-2025)

4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2026-2031)

5 Drugs for Short Bowel Syndrome Breakdown Data by Application

5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2020-2025)

5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drugs for Short Bowel Syndrome Market Size (2020-2031)

6.2 North America Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drugs for Short Bowel Syndrome Market Size by Country (2020-2025)

6.4 North America Drugs for Short Bowel Syndrome Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Short Bowel Syndrome Market Size (2020-2031)

7.2 Europe Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drugs for Short Bowel Syndrome Market Size by Country (2020-2025)

7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size (2020-2031)

8.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2020-2025)

8.4 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs for Short Bowel Syndrome Market Size (2020-2031)

9.2 Latin America Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2020-2025)

9.4 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size (2020-2031)

10.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2020-2025)

10.4 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ardelyx

11.1.1 Ardelyx Company Details

11.1.2 Ardelyx Business Overview

11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction

11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.1.5 Ardelyx Recent Development

11.2 Emmaus Life Sciences

11.2.1 Emmaus Life Sciences Company Details

11.2.2 Emmaus Life Sciences Business Overview

11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction

11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.2.5 Emmaus Life Sciences Recent Development

11.3 GLyPharma Therapeutic

11.3.1 GLyPharma Therapeutic Company Details

11.3.2 GLyPharma Therapeutic Business Overview

11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction

11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.3.5 GLyPharma Therapeutic Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Drugs for Short Bowel Syndrome Introduction

11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Naia Pharmaceuticals

11.5.1 Naia Pharmaceuticals Company Details

11.5.2 Naia Pharmaceuticals Business Overview

11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction

11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.5.5 Naia Pharmaceuticals Recent Development

11.6 Nutrinia

11.6.1 Nutrinia Company Details

11.6.2 Nutrinia Business Overview

11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction

11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.6.5 Nutrinia Recent Development

11.7 OxThera

11.7.1 OxThera Company Details

11.7.2 OxThera Business Overview

11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction

11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.7.5 OxThera Recent Development

11.8 Sancilio & Company

11.8.1 Sancilio & Company Company Details

11.8.2 Sancilio & Company Business Overview

11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction

11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.8.5 Sancilio & Company Recent Development

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction

11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.9.5 Takeda Recent Development

11.10 Zealand Pharma

11.10.1 Zealand Pharma Company Details

11.10.2 Zealand Pharma Business Overview

11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction

11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2020-2025)

11.10.5 Zealand Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ardelyx Inc

Emmaus Life Sciences

GLyPharma Therapeutic

Merck

Naia Pharmaceuticals

Nutrinia

OxThera

Sancilio & Company

Takeda

Zealand Pharma

Sancilio & Company

List of Tables

Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of GLP-2

Table 3. Key Players of Growth Hormone

Table 4. Key Players of Glutamine

Table 5. Key Players of Other

Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drugs for Short Bowel Syndrome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Drugs for Short Bowel Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Drugs for Short Bowel Syndrome Market Share by Region (2020-2025)

Table 10. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Drugs for Short Bowel Syndrome Market Share by Region (2026-2031)

Table 12. Drugs for Short Bowel Syndrome Market Trends

Table 13. Drugs for Short Bowel Syndrome Market Drivers

Table 14. Drugs for Short Bowel Syndrome Market Challenges

Table 15. Drugs for Short Bowel Syndrome Market Restraints

Table 16. Global Drugs for Short Bowel Syndrome Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Drugs for Short Bowel Syndrome Market Share by Players (2020-2025)

Table 18. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2024)

Table 19. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Drugs for Short Bowel Syndrome, Headquarters and Area Served

Table 22. Global Key Players of Drugs for Short Bowel Syndrome, Product and Application

Table 23. Global Key Players of Drugs for Short Bowel Syndrome, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drugs for Short Bowel Syndrome Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2020-2025)

Table 27. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2026-2031)

Table 29. Global Drugs for Short Bowel Syndrome Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2020-2025)

Table 31. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2026-2031)

Table 33. North America Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Drugs for Short Bowel Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Drugs for Short Bowel Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Drugs for Short Bowel Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Drugs for Short Bowel Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Drugs for Short Bowel Syndrome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 48. Ardelyx Company Details

Table 49. Ardelyx Business Overview

Table 50. Ardelyx Drugs for Short Bowel Syndrome Product

Table 51. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 52. Ardelyx Recent Development

Table 53. Emmaus Life Sciences Company Details

Table 54. Emmaus Life Sciences Business Overview

Table 55. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product

Table 56. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 57. Emmaus Life Sciences Recent Development

Table 58. GLyPharma Therapeutic Company Details

Table 59. GLyPharma Therapeutic Business Overview

Table 60. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product

Table 61. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 62. GLyPharma Therapeutic Recent Development

Table 63. Merck Company Details

Table 64. Merck Business Overview

Table 65. Merck Drugs for Short Bowel Syndrome Product

Table 66. Merck Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 67. Merck Recent Development

Table 68. Naia Pharmaceuticals Company Details

Table 69. Naia Pharmaceuticals Business Overview

Table 70. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product

Table 71. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 72. Naia Pharmaceuticals Recent Development

Table 73. Nutrinia Company Details

Table 74. Nutrinia Business Overview

Table 75. Nutrinia Drugs for Short Bowel Syndrome Product

Table 76. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 77. Nutrinia Recent Development

Table 78. OxThera Company Details

Table 79. OxThera Business Overview

Table 80. OxThera Drugs for Short Bowel Syndrome Product

Table 81. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 82. OxThera Recent Development

Table 83. Sancilio & Company Company Details

Table 84. Sancilio & Company Business Overview

Table 85. Sancilio & Company Drugs for Short Bowel Syndrome Product

Table 86. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 87. Sancilio & Company Recent Development

Table 88. Takeda Company Details

Table 89. Takeda Business Overview

Table 90. Takeda Drugs for Short Bowel Syndrome Product

Table 91. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 92. Takeda Recent Development

Table 93. Zealand Pharma Company Details

Table 94. Zealand Pharma Business Overview

Table 95. Zealand Pharma Drugs for Short Bowel Syndrome Product

Table 96. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2020-2025) & (US$ Million)

Table 97. Zealand Pharma Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Drugs for Short Bowel Syndrome Picture

Figure 2. Global Drugs for Short Bowel Syndrome Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drugs for Short Bowel Syndrome Market Share by Type: 2024 VS 2031

Figure 4. GLP-2 Features

Figure 5. Growth Hormone Features

Figure 6. Glutamine Features

Figure 7. Other Features

Figure 8. Global Drugs for Short Bowel Syndrome Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Drugs for Short Bowel Syndrome Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Drugs for Short Bowel Syndrome Report Years Considered

Figure 14. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Drugs for Short Bowel Syndrome Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Drugs for Short Bowel Syndrome Market Share by Region: 2024 VS 2031

Figure 17. Global Drugs for Short Bowel Syndrome Market Share by Players in 2024

Figure 18. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2024

Figure 20. North America Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Drugs for Short Bowel Syndrome Market Share by Country (2020-2031)

Figure 22. United States Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Drugs for Short Bowel Syndrome Market Share by Country (2020-2031)

Figure 26. Germany Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Region (2020-2031)

Figure 34. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Drugs for Short Bowel Syndrome Market Share by Country (2020-2031)

Figure 42. Mexico Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Country (2020-2031)

Figure 46. Turkey Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Drugs for Short Bowel Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 50. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 51. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 53. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 54. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 55. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 56. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 57. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 58. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colonoscopy Bowel Preparation Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Multisystem Inflammatory Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Short Bowel Syndrome SBS Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Specialty Generics Market

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sicca Syndrome Drug Market Research Report 2024

Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Crohn s Disease Drug Market Research Report 2024

Global IBD Ulcerative Colitis and Crohn s Disease Treatment Market Insights Forecast to 2030

PPIs Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025

Global Antidiarrheals Market Insights Forecast to 2030

Infectious Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions